OmniAb, Inc. (OABI) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 677.52M USD. 52-week range 1.30 to 5.43 USD. Data as of 2026-10-09.
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune ...